Mechanisms and Pharmacology of Bone Cancer Pain
Bone cancer pain is common in patients with advanced breast, prostate and lung cancer as these tumors have a remarkable affinity to metastasize to bone. Bone cancer pain is very common and patients with this type of pain may be difficult to treat.
Some models of bone cancer pain, which closely mirror the human condition, are providing insight into the mechanisms that drive bone cancer pain and guide the development of mechanism-based therapies to treat the cancer pain.
In this webinar, we will discuss clinical symptoms of bone cancer pain and the mechanisms involved in this disease. We will focus on pharmacological approach in the drug discovery models and possible future treatments to improve the quality of life, functional status and survival of patients with bone cancer.
Speaker
Laurent DIOP
Chief Scientific Officer
Dr. Diop earned his Ph.D. in Molecular and Cellular Biology and has held senior leadership positions within various pharmaceutical companies (Jouveinal, Parke-Davis, Pfizer) where he actively contributed to drug development projects in digestive motility and visceral pain. In particular, he led R&D programs designed to evaluate the efficacy of new compounds for the treatment of IBS and IBD. He has co-authored 6 patents, 41 research articles, 3 book chapters and over 70 published abstracts.
Moderated by Quitterie Brossard – ATLANTIC BONE SCREEN – ANS Biotech’s partner
Business Development Manager in a 10-year-old French CRO, specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and biomaterials.